Tag Archives: 68521-88-0

Trimethoprim-sulfamethoxazole (co-trimoxazole) may be the primary drug used for oral eradication

Posted on December 12, 2019 by Terrence Simpson

Trimethoprim-sulfamethoxazole (co-trimoxazole) may be the primary drug used for oral eradication therapy of infections (melioidosis). to 20 weeks of oral trimethoprim-sulfamethoxazole with or without doxycycline. Trimethoprim and sulfamethoxazole inhibit the folic acid biosynthetic pathway by targeting dihydrofolate reductase (FolA) and … Continue reading →

Posted in Main | Tagged , | Comments Off on Trimethoprim-sulfamethoxazole (co-trimoxazole) may be the primary drug used for oral eradication

Using pregnenolone and 7-deoxycholic acid as starting materials, some 17-acetamidoandrostane and

Posted on July 1, 2019 by Terrence Simpson

Using pregnenolone and 7-deoxycholic acid as starting materials, some 17-acetamidoandrostane and against two tumor cell lines: SGC 7901 (human being gastric carcinoma) and Bel 7404 (human being liver carcinoma). for Cell Viability SGC 7901 (human being gastric carcinoma) and Bel … Continue reading →

Posted in Main | Tagged , | Comments Off on Using pregnenolone and 7-deoxycholic acid as starting materials, some 17-acetamidoandrostane and